These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice. Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ. Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094 [Abstract] [Full Text] [Related]
3. Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue. O'Byrne KJ, Ennis JT, Freyne PJ, Clancy LJ, Prichard JS, Carney DN. Br J Cancer; 1994 Apr; 69(4):762-6. PubMed ID: 7908220 [Abstract] [Full Text] [Related]
4. [Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small-cell bronchial carcinoma]. Hoefer M, Schmidt S, Welter J, Kirsch CM, Ukena D, Sybrecht GW. Pneumologie; 1998 Feb; 52(2):106-12. PubMed ID: 9557059 [Abstract] [Full Text] [Related]
5. Indium-111-DTPA-octreotide scintigraphy modulation by treatment with unlabelled somatostatin analogue in small-cell lung cancer. Soresi E, Bombardieri E, Chiti A, Boffi R, Invernizzi G, Crippa F, Maffioli L. Tumori; 1995 Feb; 81(2):125-7. PubMed ID: 7778214 [Abstract] [Full Text] [Related]
6. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide. Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW. Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760 [Abstract] [Full Text] [Related]
8. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Kirsch CM, von Pawel J, Grau I, Tatsch K. Eur J Nucl Med; 1994 Dec; 21(12):1318-25. PubMed ID: 7875170 [Abstract] [Full Text] [Related]
9. High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69). Taylor JE, Coy DH, Moreau JP. Life Sci; 1988 Dec; 43(5):421-7. PubMed ID: 2899828 [Abstract] [Full Text] [Related]
15. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung. Traub T, Petkov V, Ofluoglu S, Pangerl T, Raderer M, Fueger BJ, Schima W, Kurtaran A, Dudczak R, Virgolini I. J Nucl Med; 2001 Sep; 42(9):1309-15. PubMed ID: 11535718 [Abstract] [Full Text] [Related]
16. Evaluation of (111)In labeled somatostatin analogs for targeted therapy of somatostatin receptor positive tumors. Bernhardt P, Ahlman H, Nilsson O, Benjegård SA, Forssell-Aronsson E. Cancer Biother Radiopharm; 2003 Apr; 18(2):249-52. PubMed ID: 12804051 [No Abstract] [Full Text] [Related]
17. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Reubi JC, Waser B, Sheppard M, Macaulay V. Int J Cancer; 1990 Feb 15; 45(2):269-74. PubMed ID: 1968052 [Abstract] [Full Text] [Related]